Omnicell Inc

OMCL

32.110USD

-1.010-3.05%

Close 09/05, 16:00（ET）Quotes delayed by 15 min

Score

Industry at a Glance

Industry Ranking

66 / 280

Overall Ranking

148 / 4731

Industry

Healthcare Services & Equipment

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 8 analysts

Buy

Current Rating

44.000

Target Price

+37.03%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 121.87.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD 12.53M.%!(EXTRA int=2)

Overvalued

The company’s latest PE is 63.84, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 49.10M shares, decreasing 15.98% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 5.62M shares of this stock.

The company's current financial score is 7.14, which is lower than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 269.67M, representing a year-over-year increase of 9.55%, while its net profit experienced a year-over-year increase of 55.20%.

Score

Industry at a Glance

Previous score

7.14

Change

0



Financials

9.43

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

4.47

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.51

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.21

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.10

Key Metrics

Free cash flow

No Data

The company’s current valuation score is 4.80, which is higher than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 66.07, which is -9.19% below the recent high of 60.00 and 238.42% above the recent low of -91.45.

Score

Industry at a Glance

Previous score

4.80

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 66/280

No Data

The company’s current earnings forecast score is 7.25, which is lower than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Omnicell Inc is 41.00, with a high of 55.00 and a low of 34.00.

Score

Industry at a Glance

Previous score

7.25

Change

0

Support & Resistance

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The company’s current price momentum score is 8.70, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 35.18 and the support level at 30.09, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.34

Change

-1.64

Support & Resistance

No Data

Institutional Confidence

Currency: USD Updated：2025-09-05

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 106.89%, representing a quarter-over-quarter decrease of 0.26%. The largest institutional shareholder is The Vanguard, holding a total of 5.62M shares, representing 12.23% of shares outstanding, with 2.02% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

6.94M

-2.80%

The Vanguard Group, Inc.

Star Investors

5.56M

+0.21%

Dimensional Fund Advisors, L.P.

1.88M

+14.73%

State Street Global Advisors (US)

2.17M

-3.52%

Lazard Asset Management, L.L.C.

1.65M

+0.23%

Nikko Asset Management Co., Ltd.

1.41M

-3.07%

D. E. Shaw & Co., L.P.

1.40M

+48.39%

Victory Capital Management Inc.

1.68M

+10.09%

Macquarie Investment Management

1.14M

+2.51%



1

2



The company's beta value is 0.82. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Omnicell Inc

OMCL

6.62 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Insulet Corp

PODD

7.89 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Merit Medical Systems Inc

MMSI

7.81 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Tenet Healthcare Corp

THC

7.67 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Brightspring Health Services Inc

BTSG

7.65 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

7.64 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.